In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Terns Pharmaceuticals Inc (NASDAQ: TERN) was $18.19 for the day, up 4.36% from the previous closing price of $17.43. In other words, the price has increased by $4.36 from its previous closing price. On the day, 4.37 million shares were traded. TERN stock price reached its highest trading level at $18.6 during the session, while it also had its lowest trading level at $16.8301.
Ratios:
Our analysis of TERN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 24.70 and its Current Ratio is at 24.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $20.Truist initiated its Buy rating on October 15, 2025, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 04 ’25 when Quigley Jill M. sold 24,520 shares for $18.00 per share. The transaction valued at 441,360 led to the insider holds 0 shares of the business.
JILL QUIGLEY bought 24,520 shares of TERN for $344,016 on Nov 04 ’25. On Oct 01 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 944 shares for $7.85 each. As a result, the insider received 7,407 and left with 51,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 1591826048 and an Enterprise Value of 1211005568.
Stock Price History:
The Beta on a monthly basis for TERN is -0.23, which has changed by 1.4688385 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $18.75, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 118.58%, while the 200-Day Moving Average is calculated to be 254.94%.
Shares Statistics:
TERN traded an average of 2.02M shares per day over the past three months and 6617270 shares per day over the past ten days. A total of 87.47M shares are outstanding, with a floating share count of 69.63M. Insiders hold about 20.43% of the company’s shares, while institutions hold 83.32% stake in the company. Shares short for TERN as of 1760486400 were 10361211 with a Short Ratio of 5.13, compared to 1757894400 on 8308078. Therefore, it implies a Short% of Shares Outstanding of 10361211 and a Short% of Float of 11.84.
Earnings Estimates
The stock of Terns Pharmaceuticals Inc (TERN) is currently in the spotlight, with 9.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.27 and low estimates of -$0.38.
Analysts are recommending an EPS of between -$1.04 and -$1.25 for the fiscal current year, implying an average EPS of -$1.13. EPS for the following year is -$1.24, with 10.0 analysts recommending between -$0.81 and -$1.49.
